 |
Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity |
Stewart, Scott G.; Hill, Timothy A.; Gilbert, Jayne; Ackland, Stephen P.; Sakoff, Jennette A.... More
|
2007 |
—
|
|
 |
A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients |
Garg, Madhu B.; Sakoff, Jennette A.; Ackland, Stephen P. |
2011 |
—
|
|
 |
Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition |
Sakoff, Jennette A.; Howitt, Ian J.; Ackland, Stephen P.; McCluskey, Adam |
2004 |
—
|
|
 |
Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect |
Garg, Madhu B.; Ackland, Stephen P. |
2011 |
—
|
|
 |
Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer |
Wong, Mark; Balleine, Rosemary L.; Hoskins, Janelle M.; Mann, Graham J.; Clarke, Christine L.... More
|
2006 |
—
|
|
 |
Norcantharimides, synthesis and anticancer activity: synthesis of new norcantharidin analogues and their anticancer evaluation |
Hill, Timothy A.; Stewart, Scott G.; Ackland, Stephen P.; Gilbert, Jayne; Sauer, Benjamin... More
|
2007 |
—
|
|
 |
Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition |
Hill, Timothy A.; Stewart, Scott G.; Gordon, Christopher P.; Ackland, Stephen P.; Gilbert, Jayne... More
|
2008 |
—
|
|
 |
Nab-paclitaxel: a bright new SPARC in taxane therapy of cancer (editorial) |
Ackland, Stephen P.; Bull, James M.; Boyle, Frances M. |
2009 |
—
|
|
 |
Heterocyclic substituted cantharidin and norcantharidin analogues-synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity |
Hill, Timothy A.; Stewart, Scott G.; Sauer, Benjamin; Gilbert, Jayne; Ackland, Stephen P.... More
|
2007 |
—
|
|
 |
Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas |
Goldstein, David; Gainford, M Corona; Miller, Danielle; Shannon, Jenny; Brown, Chris... More
|
2011 |
—
|
|
 |
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study |
Tebbutt, Niall C.; Wilson, Kate; Forgeson, Garry; Cunningham, David; Saunders, Mark P.... More
|
2010 |
—
|
|
 |
Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A |
McCluskey, Adam; Walkom, Cecilia; Bowyer, Michael C.; Ackland, Stephen P.; Gardiner, Emma... More
|
2001 |
—
|
|
 |
Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines |
McCluskey, Adam; Ackland, Stephen P.; Bowyer, Michael C.; Baldwin, Monique L.; Garner, James... More
|
2003 |
—
|
|